Biogen CEO on Revolutionizing Drug Development for Rare Diseases with n-Lorem | CHRISTOPHER A. VIEHBACHER, PRESIDENT AND CHIEF EXECUTIVE OFFICER OF BIOGEN 00:10:00
Christopher A. Viehbacher joined Biogen as President and Chief Executive Officer and a member of the Board of Directors in November 2022. Viehbacher has extensive international experience in both large pharmaceutical companies and entrepreneurial biotech companies and has a passion for advancing science for the benefit of patients and public health. After 20 years with GlaxoSmithKline, he served as global CEO of Sanofi for six years. Under Viehbacher’s leadership, Sanofi strengthened and diversified its R&D pipeline and delivered significant value to shareholders.
